Fig. 1From: Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysisPreferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) sheetBack to article page